You should include patients waiting from referral/upgrade date by the number of days waited at midnight Sunday of the reporting week.
Patients are recorded under time brackets for each individual tumour type according to how long they have been waiting on the pathway. The time brackets are:
- day 0-33
- day 34-62
- day 63-104
- day >104 (that is, 105 days and more)
For each individual tumour type the number of patients passing 62 days waiting, and the number of patients passing 104 days in the last 7 days are recorded.
Urgent suspected cancer
Patients on a 62-day pathway who are referred for urgent suspected cancer (two-week wait) referral.
Patients are recorded according to the tumour type they are referred under.
If the patient has been transferred to another team within the trust on the suspicion of a different type of cancer, the patient should be recorded under this tumour type and new team.
To ensure ease of collection and to make sure all metrics are feasible to be submitted accurately, we will not be asking to collect numbers of acute leukaemia waiters separately from haematological, nor testicular from urological.
Patients referred on the two-week urgent breast symptomatic standard (where cancer is not suspected).
Patients referred urgently from one of the three national screening services (breast, bowel and cervical).
Patients who subsequently have their tumour type updated after investigations should continue to be recorded under the screening service they were referred from until they are removed from the PTL.
Patients who have had their pathway upgraded from a referral to treatment (RTT) pathway to a 62-day pathway.
This covers patients with a first primary cancer only.